Delivery Order SPE2DB24D8003-SPE2DB25FJTDH

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D8003 and SPE2DB25FJTJU, is for the delivery of DEXCOM G7 SENSORS to the Defense Logistics Agency (DLA). The $2,867.62 Firm Fixed Price contract was awarded on December 4, 2024 to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has an ultimate completion date of December 5, 2024 and is not associated with any set-aside designation. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $1,033.26 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DEXCOM G7 SENSORS. This award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support Medical's ECAT...
This is a $2,207.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the procurement of Dexcom G7 continuous glucose monitoring sensors to support U.S. Armed Forces medical operations. The delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of DEXCOM G6 sensor 3S medical devices. The total ceiling value of the order is $4,197.49, with a period of performance through October 28, 2024. The award is part of DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. This IDC allows the company to...
This federal contract award, valued at $2,464.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, with a completion date of July 1, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designations. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of DEXCOM G7 SENSORS, which are medical devices used for the management of diabetes. The $4,095.60 contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which covers a broad...
This federal contract award, valued at $1,022.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used in the management of diabetes. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,042.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, and has an ultimate completion date of February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not designated with any set-aside requirements, indicating open competition....
This federal contract award is for DEXCOM G7 SENSORS, a medical device product, valued at $8,063.37. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $1,675.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used in the management of diabetes. The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTDH
    Delivery Order

This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTDH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract, valued at $2,186.47, is for the delivery of DEXCOM G7 SENSORS, a type of medical device. The contract has an ultimate completion date of October 18, 2024 and is a firm fixed-price delivery order.

Dakota Drug, Inc. is a self-certified small disadvantaged business registered in the System for Award Management (SAM.gov). The company specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, with a focus on serving the Department of Defense through the DLA.

In addition to this contract, Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT Generation V Program, allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.

Generated 1/16/25, 9:32 AM